Open AccessEnzalutamide alleviates anxiety and depression as well as improves quality of life compared to bicalutamide in metastatic castration-resistant prostate cancer patients: a cohort study
Author(s) -
Feng Guo,
Guohao Li
Publication year - 2019
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2019.09.12
Subject(s) - bicalutamide , enzalutamide , prostate cancer , hospital anxiety and depression scale , medicine , anxiety , depression (economics) , quality of life (healthcare) , oncology , cohort , cancer , androgen receptor , psychiatry , nursing , economics , macroeconomics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom